Malaysian pharmaceutical company Pharmaniaga Bhd has exited PN17 status after successfully implementing its regularization plan. This involved a capital reduction of RM520 million, effectively wiping out accumulated losses. The completion marks a significant milestone for the company's financial recovery.
This article has been processed for multi-language support.